趙子龍

2006.09 - 2009.06，中國科學院化學研究所，博士（物理化學）；

2003.09 - 2006.06，湖南師範大學，碩士（分析化學）；

1999.09 - 2003.06，湖南師範大學，學士 ^[1] 

2013.12 - 2016.12，湖南大學生物學院，副研究員；

2011.11 - 2013.11，湖南大學，博士後；

2010.01 - 2011.01，美國佛羅里達大學，博士後 ^[1] 

化學生物學、納米生物學 ^[1] 

1、國家自然科學基金青年基金，特異性識別胰導管腺癌核酸適配體的篩選及其診治應用的初步研究（21405041），2015.01-2017.12，25萬元，主持；

2、國家自然科學基金國家重大科研儀器研製項目，基於核酸適配體識別的腫瘤細胞新型標誌物高效篩選儀的研製子課題（61527806），2016.01-2020.12，214萬元，主持 ^[1] 

（#共同第一作者，*通訊作者）：

[14]. Ying Jiang, Xiaoshu Pan, Jin Chang, Weijia Niu, Weijia Hou, Hailan Kuai, Zilong Zhao*, Ji Liu, Ming Wang*, Weihong Tan*, Supramolecularly Engineered Circular Bivalent Aptamer for Enhanced Functional Protein Delivery, J. Am. Chem. Soc., 2018, DOI: 10.1021/jacs.8b03442.

[13]. Yongbo Peng#, ZilongZhao#*, TengLiu#, XiongLi, Xiaoxiao Hu, Xiaoping Wei, XiaobingZhang, WeihongTan*, Smart Human-Serum-Albumin-As2O3 Nanodrug with Self-Amplified Folate Receptor-Targeting Ability for Chronic Myeloid Leukemia Treatment, Angew. Chem. Int. Ed., 2017, 56(36): 10845-10849.

[12]. Xuan Yu, Liang Gong, Jing Zhang, Zilong Zhao*, Xiaobing Zhang*, Weihong Tan*, Nanocarrier Based on the Assembly of Protein and Antisense Oligonucleotide to Combat Multidrug Resistance in Tumor Cells, Science China Chemistry, 2017, 60(10): 1318-1323. ^[1] 

[11]. Wenting Jia, Caiping Ren*, Lei Wang, Bin Zhu, Wei Jia, Menghui Gao, Fei Zeng, Liang Zeng, Xiaomeng Xia, Xiaobing Zhang, Ting Fu, Shasha Li, Can Du, Xingjun Jiang, Yuxiang Chen, Weihong Tan, Zilong Zhao*, Weidong Liu*, CD109 Is Identified as a Potential Nasopharyngeal Carcinoma Biomarker Using Aptamer Selected by Cell-SELEX, 2016, Oncotarget, 2016, 7(34): 55328-55342.

[10]. Hailan Kuai#, Zilong Zhao#, Liuting Mo, Hui Liu, Xiaoxiao Hu, Ting Fu, Xiaobing Zhang, Weihong Tan*, Circular Bivalent Aptamers Enable in vivo Stability and Recognition, J. Am. Chem. Soc., 2017, 139(27): 9128-9131.

[9]. Yongbo Peng#, Zilong Zhao#, Teng Liu#, Guojian Xie, Cheng Jin, Tanggang Deng, Yang Sun, Xiong Li, Xiaoxiao Hu, Xiaobing Zhang, Mao Ye, Weihong Tan*, A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance, ChemMedChem, 2017, 12(3): 250-256.

[8]. Xia Li#, Bo Zhou#, Zilong Zhao#, Zixi Hu, Sufang Zhou, Nuo Yang, Yong Huang, Zhenghua Zhang, Jing Su, Dan Lan, Xue Qin, Jinyu Meng, Duo Zheng, Jian He,Xianing Huang, Jing Zhao, Zhiyong Zhang, Weihong Tan*, Xiaoling Lu*, Yongxiang Zhao*, A Smart Detection System Based on Specific Magnetic and Rolling Cycle Amplification Signal-Amplified Dual-Aptamers to Accurately Monitor Minimal Residual Diseases in Patients with T-ALL, J. Biomed. Nanotechnol., 2016, 12(12): 2151-2160.

[7]. Huanhuan Fan#, Zilong Zhao#, Guobei Yan, Xiaobing Zhang, Chao Yang, Hongmin Meng, Zhuo Chen, Hui Liu, Weihong Tan*, A Smart DNAzyme–MnO2 Nanosystem for Efficient Gene Silencing, Angew. Chem. Int. Ed., 2015, 54(16): 4801-4805.

[6]. Jun Hu#, Zilong Zhao#, Qiaoling Liu, Mao Ye, Bingqiang Hu, Jing Wang, Weihong Tan*, Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma, Chem. Asian J., 2015, 10(7): 1519-1525.

[5]. Xiaoqiu Wu#, Zilong Zhao#, Huarong Bai, Ting Fu, Chao Yang, Xiaoxiao Hu, Qiaoling Liu, Carole Champanhac, I-Ting Teng, Mao Ye*, Weihong Tan*, DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition, Theranostics, 2015, 5(9): 985-994.

[4]. Zilong Zhao#, Huanhuan Fan#, Gaofeng Zhou, Huarong Bai, Hao Liang, Ruowen Wang, Xiaobing Zhang, Weihong Tan*, Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO2 Nanosheet-Aptamer Nanoprobe, J. Am. Chem. Soc., 2014, 136(32): 11220-11223. （高被引論文）

[3]. Nannan Wang#, Zilong Zhao#, Yifan Lv, Huanhuan Fan, Huarong Bai, Hongmin Meng, Yuqian Long, Ting Fu, Xiaobing Zhang, Weihong Tan*, Gold Nanorod-Photosensitizer Conjugate with Extracellular pH-Driven Tumor Targeting Ability for Photothermal/Photodynamic Therapy, Nano Research, 2014,7(9): 1291-1301.

[2]. Zilong Zhao, Hongmin Meng, Nannan Wang, Micheal J Donovan, Ting Fu, Mingxu You, Zhuo Chen, Xiaobing Zhang*, Weihong Tan*, A Controlled-Release Nanocarrier with Extracellular pH Value Driven Tumor Targeting and Translocation for Drug Delivery, Angew. Chem. Int. Ed., 2013, 52(29): 7487-7491.

[1]. Zilong Zhao, Li Xu, Xiaoli Shi, Weihong Tan, Xiaohong Fang*, Dihua Shangguan*, Recognition of Subtype Non-Small Cell Lung Cancer by DNA Aptamers Selected from Living Cells, Analyst, 2009, 134(9): 1808-1814. ^[1]